Table 3.
Correlation between recurrence and clinicopathological factors and MRI findings in young breast cancer patients (n = 92).
| Clinicopathological Factor | Recurrence, N (%) | p-value | |
|---|---|---|---|
| No | Yes | ||
| Age, years | 0.50 | ||
| ≤30 | 16 (80.0) | 4 (20.0) | |
| >30 | 55 (76.4) | 17 (23.6) | |
| Lesion Type | 0.04 | ||
| Mass only | 49 (84.5) | 9 (15.5) | |
| Non-mass enhancement | 22 (64.7) | 12 (35.3) | |
| Multifocality at MRI* | 0.07 | ||
| No | 41 (83.7) | 8 (16.3) | |
| Yes | 28 (68.3) | 13 (31.7) | |
| Multicentricity at MRI ^ | 0.38 | ||
| No | 46 (79.3) | 12 (20.7) | |
| Yes | 23 (74.2) | 8 (25.8) | |
| Tumor size at MRI | 0.01 | ||
| T1 | 25 (96.2) | 1 (3.8) | |
| T2 | 31 (72.1) | 12 (27.9) | |
| T3 | 15 (65.2) | 8 (34.8) | |
| Molecular Subtype # | 0.72 | ||
| Luminal A | 8 (72.7) | 3 (27.3) | |
| Luminal B | 29 (70.7) | 12 (29.3) | |
| Her2 | 7 (70.0) | 3 (30.0) | |
| Triple-negative | 16 (84.2) | 3 (15.8) | |
| Tumor size at Pathology + | 0.01 | ||
| T1 | 26 (100) | 0 (0) | |
| T2 | 24 (72.7) | 9 (27.3) | |
| T3 | 8 (72.7) | 3 (27.3) | |
| Associated DCIS α | 0,28 | ||
| No | 22 (81.5) | 5 (18.5) | |
| Yes | 43 (72.9) | 16 (27.1) | |
| Multifocality at Pathology β | 0.40 | ||
| No | 40 (74.1) | 14 (25.9) | |
| Yes | 10 (83.3) | 2 (16.7) | |
| Multicentricity at Pathology χ | 0.50 | ||
| No | 40 (75.5) | 13 (24.5) | |
| Yes | 9 (81.8) | 2 (18.2) | |
| Axillary Metastasis # | <0.01 | ||
| No | 45 (93.8) | 3 (6.3) | |
| Yes | 18 (54.5) | 15 (45.5) | |
Missing data points: *n = 2; ^n = 3; #n = 11; +n = 22; αn = 6; βn = 26; χn = 28.